Partnerships in Technology Transfer: The NIH Experience
description
Transcript of Partnerships in Technology Transfer: The NIH Experience
![Page 1: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/1.jpg)
Partnerships in Technology Transfer: The NIH Experience
Luis A. Salicrup, Ph.D.Senior Advisor for International ActivitiesOffice of Technology TransferNational Institutes of HealthU.S. Department of Health & Human Services
FLC MeetingSeptember 14, 2005
![Page 2: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/2.jpg)
NIH Mission
To uncover new knowledge that will lead to improved
public health
![Page 3: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/3.jpg)
National Institutes of HealthBasic Biomedical Research in Support of the Public Health
Funding
Training
Basic Research
Clinical Trials
Inventions
Policies
![Page 4: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/4.jpg)
Importance of Global Health Research
Humanitarian Objectives
Globalization of Health Problems
and their Relevance to Domestic Health
Economic Development and Political Stability
![Page 5: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/5.jpg)
Relevance of Technology Transfer to Institutions in Developing Countries
Innovation of all types
National, regional and global needs
Reduction of the burden of disease worldwide
10/90 GAP
![Page 6: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/6.jpg)
New Trends in Health Entities in LDCs• Increase in public-private partnerships• Developing countries (India, Brazil,
China, South Africa) strengthening investments in biotechnology research of endemic and neglected diseases
• Developing country institutions entering various types of R&D agreements for transferring technologies
![Page 7: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/7.jpg)
Partners for Global Health
NIH OTT currently active exploring ways to enhance the process of transferring technologies to institutions in: – Asia
– Latin America
– Africa
– Eastern Europe
![Page 8: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/8.jpg)
Collaborative work with institutions in developing countries has revealed needs and opportunities for transfer of NIH technologies related to:
• HIV/AIDS• Tuberculosis• Malaria• Dengue• Pertussis• Meningitis
• Rotavirus• Typhoid Fever• Cancer • Diabetes• Medical Devices &
Animal Models
![Page 9: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/9.jpg)
Capacity Building at NIH-OTT
Information Access
Combined initiative by NIH-OTT and U.S. academic institutions
Database of technologies for neglected diseases
Resource tool for managers and scientists in developing countries
![Page 10: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/10.jpg)
International Technology Transfer Internship Program
Aimed to train Scientists and Managers
Provide key exposure & practical experience
Long & Sustainable Process
Partnerships with several institutions in Asia, Africa, Latin America, and Eastern Europe
![Page 11: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/11.jpg)
Program Objectives
• Learn different aspects of IPM• Assessment & Commercialization of
Technologies • Exposure to practical aspects of
negotiation license agreement• Enhance understanding IPR Policy• Understand Global Challenges
– Clinical Trials– Capacity Building– Public-Private Partnerships
![Page 12: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/12.jpg)
Training Implementation
Rotations will depend on the needs of partners
• Different OTT Divisions and/or • NIH’s ICs’ Offices of Technology
Development• U. S. Academic Institutions
Mentors (sustainable relationship)
First Phase: Staff from institutions in China, Brazil, South Africa, India, Argentina, Hungary
![Page 13: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/13.jpg)
Additional Training
Participation in FAES/NIH TT Course
Participation in Seminars at OTT & NIH
Workshops in the field--Partners
Relevant courses & guidance at U.S. Universities
Participation in relevant professional meetings (e.g. AUTM, FLC, BIO)
![Page 14: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/14.jpg)
Lessons Learned
Participating institutions should have – Some level of R&D capabilities– Clear objectives to address national and
regional public health needs
Need to work with public and private institutions in those countries
Comprehensive, multidisciplinary, sustainable training approach
Next Steps: Evaluation/Needs Assessment
![Page 15: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/15.jpg)
ACCESSIBLE DRUGS,
DIAGNOSTICS,THERAPEUTICS
REDUCTION OF DISEASE BURDENS
(INFECTIOUS & CHRONIC)
POVERTY REDUCTION &
POTENTIAL ECONOMIC GROWTH
HEALTH TECHNOLOGIES
INNOVATION
RESEARCH & DEVELOPMENT
CAPACITY BUILDING INDEVELOPING COUNTRIES
![Page 16: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/16.jpg)
NIH CONTACTS
• NIH http://www.nih.gov• OTT http://ott.od.nih.gov• TT Training http://tttraining.od.nih.gov• Clinical Trials http://clinicaltrials.gov
E-mail: [email protected]
![Page 17: Partnerships in Technology Transfer: The NIH Experience](https://reader035.fdocuments.in/reader035/viewer/2022062807/56815075550346895dbe723f/html5/thumbnails/17.jpg)
Health for All!